Skip to main content

Table 3 Adjustment of anti-inflammatory treatment by centre

From: Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice

  Center 1
n = 20
Center 2
n = 21
Center 3
n = 14
Center 4
n = 7
Center 5
n = 8
Center 6
n = 6
Total
n = 76
Corticoids pulse — no./total no. (%)+a 5/20 (25.0) 9/21 (42.9) 9/14 (64.3) 4/5 (80.0) 6/7 (85.7) 6/6 (100) 39/71 (54.9)
Oral corticoids — no./total no. (%)a 15/20 (75.0) 18/20 (90.0) 12/14 (85.7) 3/6 (50.0) 8/8 (100) 6/6 (100) 62/74 (83.8)
Subconjonctival corticoids — no./total no. (%)a 10/19 (52.6) 5/13 (38.5) 9/14 (64.3) 3/3 (100) 6/7 (85.7) 6/6 (100) 39/62 (62.9)
Intracamerular corticoids — no./total no. (%)a 3/19 (15.8) 5/13 (38.5) 1/14 (7.1) 1/3 (33.3) 1/6 (16.7) 0/6 (0.0) 11/61 (18.0)
Corticoids eyedrops — no./total no. (%)a 19/20 (95.0) 10/10 (100) 14/14 (100) 6/6 (100) 6/6 (100) 6/6 (100) 61/62 (98.4)
Discontinuation of immunosuppressive drugs —no./total no. (%) 3/20 (15.0) 0/21 (0.0) 0/14 (0.0) 0/7 (0.0) 2/8 (25.0) 0/6 (0.0) 5/76 (6.6)
  1. aData not available for some patients